Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-07-11
2006-07-11
Romeo, David (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C514S013800, C514S806000, C530S311000, C530S324000, C530S326000, C530S327000, C530S350000, C930S160000
Reexamination Certificate
active
07074761
ABSTRACT:
The peptides and precursors thereof, inclusive salts thereof, of the present invention are useful as a pharmaceutical composition, for example as therapeutic or prophylactic agents for hormone-producing tumors, acromegaly, gigantism, dementia, gastric ulcer and the like, hormone secretion inhibitors, tumor growth inhibitors, neural activity or sleep modulators, etc. The DNAs coding for the peptides or precursors of the invention are useful as a pharmaceutical composition, for example as agents for the gene therapy or prevention of hormone-producing tumors, acromegaly, gigantism, dementia, gastric ulcer and the like, hormone secretion inhibitors, tumor growth inhibitors, neural activity or sleep modulators, etc. Furthermore, the DNAs coding for the peptides or precursors of the invention are useful as agents for the gene diagnosis of various diseases, for example, hormone-producing tumors, acromegaly, gigantism, dementia, gastric ulcer, etc. The antibodies against the peptides, precursors or salts of the invention can be used for assaying the peptides, precursors or salts of the invention in test solutions. The peptides, precursors or salts of the invention are useful as reagents for screening for compounds, or salts thereof, capable of modifying the binding of the peptides, precursors or salts of the invention to certain receptors.
REFERENCES:
patent: 6074872 (2000-06-01), Sutcliffe et al.
patent: 6232100 (2001-05-01), Olsen et al.
patent: WO 97/43417 (1997-11-01), None
Bowie et al. Deciphering the message in protein sequences: tolerance to amino acid substitutions. Science, (Mar. 16, 1990) 247 (4948) 1306-10.
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, Merz and Le Grand (Eds), Aug. 1994, Springer Verlag, pp. 433 and 492-495.
Sherman F; Stewart J W; Tsunasawa S. Methionine or not methionine at the beginning of a protein. Bioessays, (Jul. 1985) 3 (1) 27-31.
P.C. Andrews, et al.,Isolation and Characterization of a Variant Somatostatin-14 and Two Related Somatostatins of 34 and 37 Residues from Lamprey(Petromyzon marinus)*, The Journal of Biological Chemistry, vol. 263, No. 30, 1998, pp. 15809-15814.
J. Michael Conlon, et al.,Somatostatin-Related and Glucagon-Related Peptides with Unusual Structural Features from the European Eel(Anguilla anguilla), General and Comparative Endocrinology 72, 1998, pp. 181-189.
Luis de Lecea, et al.,A Cortical Neuropeptide with Neuronal Depressant and Sleep-Modulating Properties, Letters to Nature, 1996, vol. 381, pp. 242-245.
Ronald M. Lechan, et al.,Prosomatostatin-specific antigen in rat brain; Localization by immunocytochemical staining with an antiserum to a synthetic sequence of preprosomatostatin, Proc. Natl. Acad. Sci. USA, vol. 80, 1983, pp. 2780-2784.
Fukusumi,S., et al.,Identification and Characterization of a Novel Human Cortistain-like Peptide, Biochemical and Biophysical Research Communications, Academic Press, Inc., Orland, FL, US, vol. 232, No. 1, Mar. 6, 1997, pp. 157-163.
Fukusumi,S., et al.,Identification of a Novel Cortistain-like Peptide in Human, Pepuchido Kagaku Toronkai Koen Yoshishu, 1996 vol. 34, pp. 9, Retrieved from STN Database accession No. 970321252 (Abstract).
Lecea de,L., et al.,Cloning, mRNA Expression, and Chromosonal Mapping of Mouse and Human Preprocortistain, Genomics, Academic Press, San Diego, US, vol. 42, No. 3, Jun. 15, 1997, pp. 499-506.
Totstivint, H., et al.,Un deuxiéme gene codant pour la somatostatine est exprimé dans le cerveau, M/S Médecine Sciences, Societe des Periodiques Flammarion, Paris, FR, vol. 12, No. 10, Oct. 1, 1996, pp. 1131-1133.
O. Prospero-Garcia, et al.,Cortistatin Modulates Cortical and Hippocampal Electrophysiological Activity and Sleep, Society for Neuroscience Abstracts, Society for Neuroscience, US, vol. 22, No. 1/3, Nov. 16, 1996, pp 1152 (Abstract).
Totstivint, H., et al.,Occurrence of two somatostatin variants in the frog brain: Characterization of the cDNAs, distribution of the mRNAs, and receptor-binding affinites of the peptides, Proceedings of the National Academy of Science, Washington, US, vol. 93, Oct. 1996, pp. 12605-12610.
Fukusumi, S., et al., Bioch and Biphysical Research, 232(1): pp 157-163 (Mar. 6, 1997).
DeLecea, L., et al., Letters to Nature, 381: 242-245 (May 16, 1996).
Fukusumi Shoji
Hinuma Shuji
Kitada Chieko
Conlin, Esq. David G.
Edwards Angell Palmer & & Dodge LLP
Lauro, Esq. Peter C.
Romeo David
Takeda Chemical Ind. Ltd.
LandOfFree
Peptides and production and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides and production and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and production and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3556036